These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6702326

  • 1. [Can the persistence rate of transurethrally resected bladder tumors be lowered by postoperative instillation of silver nitrate?].
    Flamm J, Grof F.
    Z Urol Nephrol; 1984 Jan; 77(1):1-6. PubMed ID: 6702326
    [Abstract] [Full Text] [Related]

  • 2. [Significance of local tumor associated infiltration of mononuclear leukocytes for persistent tumor formations following transurethral resection (TUR) of bladder cancers].
    Flamm J.
    Z Urol Nephrol; 1985 Feb; 78(2):65-70. PubMed ID: 3993242
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G, Damm O, Rosell J, Jahnson S.
    Scand J Urol Nephrol; 2008 Feb; 42(5):417-21. PubMed ID: 18609266
    [Abstract] [Full Text] [Related]

  • 4. [Dysplastic urothelial changes in patients with bladder cancer].
    Csapó Z, Kolozsy Z, Dauda G, Mohácsi L.
    Urologe A; 1984 Sep; 23(5):281-4. PubMed ID: 6542270
    [Abstract] [Full Text] [Related]

  • 5. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
    Flamm J, Grof F.
    Urologe A; 1985 Jan; 24(1):31-5. PubMed ID: 4039083
    [Abstract] [Full Text] [Related]

  • 6. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
    Hendricksen K, Gleason D, Young JM, Saltzstein D, Gershman A, Lerner S, Witjes JA.
    J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
    [Abstract] [Full Text] [Related]

  • 7. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [Abstract] [Full Text] [Related]

  • 8. [Long-term intravesical treatment with adriamycin in chemoprevention of recurrence of transurethrally resected urinary bladder cancers].
    Flamm J, Grof F.
    Wien Med Wochenschr; 1987 Jul 15; 137(13):315-7. PubMed ID: 3114964
    [Abstract] [Full Text] [Related]

  • 9. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec 15; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 10. Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?
    Schmidbauer J, Lindenau G.
    Curr Opin Urol; 2008 Sep 15; 18(5):504-7. PubMed ID: 18670275
    [Abstract] [Full Text] [Related]

  • 11. [Adjuvant local instillation with vitamin A in the therapy of bladder tumours following transurethral resection].
    Flamm J, Grof F.
    Urologe A; 1982 Jul 15; 21(4):229-31. PubMed ID: 6890262
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J.
    Z Urol Nephrol; 1987 Nov 15; 80(11):641-6. PubMed ID: 3439374
    [Abstract] [Full Text] [Related]

  • 17. [The preventive recurrent results of postoperative intravesical instillation therapy in bladder cancer].
    Zhang S, Li H, Cheng H.
    Zhonghua Wai Ke Za Zhi; 1995 May 15; 33(5):304-6. PubMed ID: 7587700
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT, Yildirim U, Zorlu F, Ozen H.
    J Urol; 2006 May 15; 175(5):1641-4. PubMed ID: 16600720
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.